OBAGI C RX system C CLARIFYING SERUM

Product NDC: 62032-106
11-digit product format: 620320106
Labeler code: 62032
Product ID: 62032-106_83215733-be55-48e1-95dc-2884132042d2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: HYDROQUINONE
Dosage form: SOLUTION
Route: TOPICAL
Labeler: Obagi Cosmeceuticals LLC
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2010-01-01
Substance: HYDROQUINONE
Active strength: 40 mg/mL
Pharmacologic classes: Depigmenting Activity [PE], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-106-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-106-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-106-10	`0efc9e666f02…`	`f202fb6c5f17…`

Additional Listing Data#

Finished product: Yes
Brand name base: OBAGI C RX system C CLARIFYING SERUM
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
HYDROQUINONE	40 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
XV74C1N1AE	Internal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9ff4f617-b8d3-46d6-8ddb-41088dd8f226	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
c5cd4727-ac49-4409-82b1-5bd8006c3ec7	Product name	1	20171122
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
1681bc73-b05f-12c3-1075-382ae39f449c	Product name	1	20140508
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
85490a6b-2306-6bf2-c51b-eb63537dc2da	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62032-106-10	2025-03-05	C162847	48780-1	2cef2736-8af0-d83d-e063-dadaa90ab31f	OBAGI-C ® RX SYSTEM
62032-106-10	2025-01-30	C162847	48780-1	2cef2736-8af0-d83d-e063-dadaa90ab31f	OBAGI-C ® RX SYSTEM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-106-10	OBAGI C RX system C CLARIFYING SERUM	30 mL in 1 BOTTLE, GLASS	SOLUTION	30		7
62032-106-10	OBAGI C RX system C CLARIFYING SERUM	1 in 1 CARTON	SOLUTION	1		7
62032-106-10	Obagi-C C-Rx System Normal-Dry Skin Intervention	30 mL in 1 BOTTLE, GLASS	SOLUTION	30 mL	40 mg in 1mL	3
62032-106-10	Obagi-C C-Rx System Normal-Dry Skin Intervention	30 mL in 1 BOTTLE, GLASS	SOLUTION	30 mL	40 mg in 1mL	3
62032-106-10	Obagi-C C-Rx System Normal-Dry Skin Intervention	1 in 1 CARTON	SOLUTION		40 mg in 1mL	3
62032-106-10	Obagi-C C-Rx System Normal-Dry Skin Intervention	1 in 1 CARTON	SOLUTION		40 mg in 1mL	3
62032-106-10	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION	1 in 1 CARTON	LIQUID		40 mg in 1mL	1
62032-106-10	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION	30 mL in 1 BOTTLE, GLASS	LIQUID	30 mL	40 mg in 1mL	1
62032-106-10	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION	1 in 1 CARTON	LIQUID		40 mg in 1mL	1
62032-106-10	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION	30 mL in 1 BOTTLE, GLASS	LIQUID	30 mL	40 mg in 1mL	1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROQUINONE	ACTIVE INGREDIENT	XV74C1N1AE	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OMP, INC.]	3
HYDROQUINONE	ACTIVE MOIETY	XV74C1N1AE	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OMP, INC.]	3
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OMP, INC.]	3
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OMP, INC.]	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OMP, INC.]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OMP, INC.]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OMP, INC.]	3
HYDROQUINONE	ACTIVE INGREDIENT	XV74C1N1AE	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROQUINONE	ACTIVE INGREDIENT	XV74C1N1AE	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROQUINONE	ACTIVE MOIETY	XV74C1N1AE	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROQUINONE	ACTIVE MOIETY	XV74C1N1AE	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
1,2-HEXANEDIOL	INACTIVE INGREDIENT	TR046Y3K1G	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
1,2-HEXANEDIOL	INACTIVE INGREDIENT	TR046Y3K1G	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CHLORPHENESIN	INACTIVE INGREDIENT	I670DAL4SZ	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CHLORPHENESIN	INACTIVE INGREDIENT	I670DAL4SZ	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROGENATED PALM GLYCERIDES	INACTIVE INGREDIENT	YCZ8EM144Q	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROGENATED PALM GLYCERIDES	INACTIVE INGREDIENT	YCZ8EM144Q	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)	INACTIVE INGREDIENT	86FQE96TZ4	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)	INACTIVE INGREDIENT	86FQE96TZ4	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
LACTIC ACID	INACTIVE INGREDIENT	33X04XA5AT	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
LACTIC ACID	INACTIVE INGREDIENT	33X04XA5AT	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
METHYLISOTHIAZOLINONE	INACTIVE INGREDIENT	229D0E1QFA	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
METHYLISOTHIAZOLINONE	INACTIVE INGREDIENT	229D0E1QFA	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PEG-10 DIMETHICONE (600 CST)	INACTIVE INGREDIENT	8PR7V1SVM0	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PEG-10 DIMETHICONE (600 CST)	INACTIVE INGREDIENT	8PR7V1SVM0	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PEG-40 STEARATE	INACTIVE INGREDIENT	ECU18C66Q7	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PEG-40 STEARATE	INACTIVE INGREDIENT	ECU18C66Q7	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PENTYLENE GLYCOL	INACTIVE INGREDIENT	50C1307PZG	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PENTYLENE GLYCOL	INACTIVE INGREDIENT	50C1307PZG	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PHENYL TRIMETHICONE	INACTIVE INGREDIENT	DR0K5NOJ4R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PHENYL TRIMETHICONE	INACTIVE INGREDIENT	DR0K5NOJ4R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
POLYOXYL 20 CETOSTEARYL ETHER	INACTIVE INGREDIENT	YRC528SWUY	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
POLYOXYL 20 CETOSTEARYL ETHER	INACTIVE INGREDIENT	YRC528SWUY	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PPG-2 MYRISTYL ETHER PROPIONATE	INACTIVE INGREDIENT	88R97D8U8A	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PPG-2 MYRISTYL ETHER PROPIONATE	INACTIVE INGREDIENT	88R97D8U8A	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM DIHYDROXYCETYL PHOSPHATE	INACTIVE INGREDIENT	YWI33EV595	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM DIHYDROXYCETYL PHOSPHATE	INACTIVE INGREDIENT	YWI33EV595	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM METABISULFITE	INACTIVE INGREDIENT	4VON5FNS3C	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM METABISULFITE	INACTIVE INGREDIENT	4VON5FNS3C	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM POLYACRYLATE (2500000 MW)	INACTIVE INGREDIENT	05I15JNI2J	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SQUALANE	INACTIVE INGREDIENT	GW89575KF9	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
SQUALANE	INACTIVE INGREDIENT	GW89575KF9	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
STEARYL ALCOHOL	INACTIVE INGREDIENT	2KR89I4H1Y	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
STEARYL ALCOHOL	INACTIVE INGREDIENT	2KR89I4H1Y	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
TETRAHEXYLDECYL ASCORBATE	INACTIVE INGREDIENT	9LBV3F07AZ	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
TETRAHEXYLDECYL ASCORBATE	INACTIVE INGREDIENT	9LBV3F07AZ	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
TROLAMINE SALICYLATE	INACTIVE INGREDIENT	H8O4040BHD	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
TROLAMINE SALICYLATE	INACTIVE INGREDIENT	H8O4040BHD	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
TROPOLONE	INACTIVE INGREDIENT	7L6DL16P1T	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
TROPOLONE	INACTIVE INGREDIENT	7L6DL16P1T	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
UBIDECARENONE	INACTIVE INGREDIENT	EJ27X76M46	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
UBIDECARENONE	INACTIVE INGREDIENT	EJ27X76M46	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-106	OBAGI C RX SYSTEM C CLARIFYING SERUM (HYDROQUINONE) SOLUTION [OBAGI COSMECEUTICALS LLC]	7	Current NDC, Legacy NDC, 2 package rows	20250308_9ff4f617-b8d3-46d6-8ddb-41088dd8f226.zip
62032-106	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1	Current NDC, Legacy NDC	20130816_d3b35a0e-cce3-4601-b18f-3e615e3bcd25.zip
62032-106	OBAGI-C RX SYSTEM NORMAL-DRY SKIN INTERVENTION ( HYDROQUINONE, OCTINOXATE AND ZINC OXIDE) KIT [OMP, INC.]	1	Current NDC, Legacy NDC	20130112_892bbe2c-cc50-4aea-99f1-0bcd1151f266.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OBAGI C RX system C CLARIFYING SERUM	HYDROQUINONE	Obagi Cosmeceuticals LLC	9ff4f617-b8d3-46d6-8ddb-41088dd8f226	2025-01-01	Warnings, Adverse reactions	Exact identifier ndc (product): 62032-106

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
XV74C1N1AE	HYDROQUINONE	123-31-9	HYDROQUINONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197795	hydroquinone 4 % Topical Cream	PSN	ca931d1c-4df4-47ce-8d5c-cd8c3e38c02b	3
197795	hydroquinone 4 % Topical Cream	PSN	e9d8488f-b902-45f4-a6d6-c6eb393c8f08	3
197795	hydroquinone 40 MG/ML Topical Cream	SCD	ca931d1c-4df4-47ce-8d5c-cd8c3e38c02b	3
197795	hydroquinone 40 MG/ML Topical Cream	SCD	e9d8488f-b902-45f4-a6d6-c6eb393c8f08	3
197795	hydroquinone 4 % Topical Cream	SY	ca931d1c-4df4-47ce-8d5c-cd8c3e38c02b	3
197795	hydroquinone 4 % Topical Cream	SY	e9d8488f-b902-45f4-a6d6-c6eb393c8f08	3
197795	hydroquinone 4 % Topical Cream	PSN	892bbe2c-cc50-4aea-99f1-0bcd1151f266	1
197795	hydroquinone 4 % Topical Cream	PSN	d3b35a0e-cce3-4601-b18f-3e615e3bcd25	1
197795	hydroquinone 40 MG/ML Topical Cream	SCD	892bbe2c-cc50-4aea-99f1-0bcd1151f266	1
197795	hydroquinone 40 MG/ML Topical Cream	SCD	d3b35a0e-cce3-4601-b18f-3e615e3bcd25	1
197795	hydroquinone 4 % Topical Cream	SY	892bbe2c-cc50-4aea-99f1-0bcd1151f266	1
197795	hydroquinone 4 % Topical Cream	SY	d3b35a0e-cce3-4601-b18f-3e615e3bcd25	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
62032-106-10	62032010610	1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS	2010-01-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Obagi-C ® C-Rx System Normal-Dry Skin Intervention	Obagi Cosmeceuticals LLC \| Bay Cities Container Corporation \| G. S. Cosmeceutical USA, Inc. \| Swiss American CDMO, LLC \| PURETEK CORPORATION	2026-01-26	HUMAN OTC DRUG LABEL	3
Obagi-C ® C-Rx System Normal-Dry Skin Intervention	Obagi Cosmeceuticals LLC \| Bay Cities Container Corporation \| G. S. Cosmeceutical USA, Inc. \| Swiss American CDMO, LLC \| Universal Packaging Systems, Inc. (DBA Paklab) \| PURETEK CORPORATION	2025-11-13	HUMAN OTC DRUG LABEL	3
OBAGI-C ® RX SYSTEM	Obagi Cosmeceuticals LLC \| G.S.COSMECEUTICAL USA, INC. \| PURETEK CORPORATION	2025-01-01	HUMAN PRESCRIPTION DRUG LABEL	7
OBAGI-C ® RX SYSTEM NORMAL-DRY SKIN INTERVENTION KIT	OMP, INC. \| PURETEK CORPORATION \| Ei INC. \| MILBAR LABORATORIES \| Bay Cities Container Corporation	2013-08-12	HUMAN PRESCRIPTION DRUG LABEL	1
OBAGI-C ® RX SYSTEM NORMAL-DRY SKIN INTERVENTION KIT	OMP, INC. \| PURETEK CORPORATION \| Ei INC. \| MILBAR LABORATORIES \| Bay Cities Container Corporation	2013-01-02	HUMAN PRESCRIPTION DRUG LABEL	1